Dr. Gian Paolo Rossi is Chair (Tenure track) of Internal Medicine, Department of Medicine-DIMED- University Hospital, Padua, Professor of Medicine, Department of Medicine University of Padua, Italy, Director of The High Blood Pressure Unit and Coordinator of the International PhD Program Arterial Hypertension Vascular Biology, University of Padua Italy. He trained at the Dept. Heart & Hypertension Research at the Cleveland Clinic and was visiting Scientist at German Institute for High Blood Pressure Research, Department of Pharmacology University of Heidelberg Germany, the Medical Academy of Gdansk  Institute of Pharmacology and Toxicology Berlin and the Egyptian Society of Hypertension.

He received his MD degree from University of Padua Magna cum laude and is Board Certified in Cardiology and in Endocrinology at the University of Padua. He received the title of Hypertension Specialist by European Society of Hypertension (ESH). He is member of European Society of Hypertension, The American College of Cardiology, The American Heart Association, The International Society of Hypertension. He has served in the Executive Board of the Italian Society of Hypertension, The European Council for Cardiovascular Research ECCR, of which was President in the term 2016-2017, and the International Aldosterone Conference, of which he was Chair in 2016-17. His also served as Editor-in-Chief of Frontiers in Cardiovascular Medicine - Hypertension section and as member of the Editorial Board of The Journal of Hypertesnion, The World Journal of Cardiology and The Journal of Clinical Endocrinology and Metabolism. He is member of the Editorial Board of Hypertension (AHA journal) and High Blood Pressure and Cardiovascular Prevention. He acted as International expert for the French INSERM for onsite visits aimed establishing new ISERM units. Known for his leadership and coordination capabilities he is coordinator of working group on Endothelins and Endothelial Factors of the ESH, Primary Aldosteronism of the Italian Society of Hypertension, Principal Investigator  of the Genica Study, the PAPY study, the PAPPHY Study, the Metras Study, the AVIS-1 and AVIS-2 Study, and the ongoing I-Padua, MAPA and EMIRA Study. He has a Hirsch Index of 65 (Google Scholar), has published 460 papers in International Journals and written 25 chapters in different Books. He was selected for the Harry Goldblatt Award of the AHA, has been awarded The Unindustria Treviso 2003 Awards, The 2013 TalalZein Award of the European Society of Hypertension, and The  2013 International Award For Publication Excellence in The Journal of Clinical Endocrinology and Metabolism of the US Endocrine Society.